Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
80.28
-3.84 (-4.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Globus Medical Revenue
In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth. Globus Medical had revenue of $657.29M in the quarter ending December 31, 2024, with 6.61% growth.
Revenue (ttm)
$2.52B
Revenue Growth
+60.62%
P/S Ratio
4.32
Revenue / Employee
$503,871
Employees
5,000
Market Cap
10.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GMED News
- 1 day ago - Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Globus Medical Reports Fourth Quarter and Full Year 2024 Results - GlobeNewsWire
- 11 days ago - NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO - Business Wire
- 16 days ago - Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewsWire
- 17 days ago - Top 2 Health Care Stocks That May Crash In February - Benzinga
- 22 days ago - Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call - GlobeNewsWire
- 6 weeks ago - Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results - GlobeNewsWire
- 6 weeks ago - The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors - Business Wire